Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2025-12-24 @ 10:58 PM
NCT ID: NCT01512069
Eligibility Criteria: Inclusion Criteria: 1. Women aged 20 years and older 2. Histologically confirmed stage 0 to III breast cancer who received curative breast cancer surgery within 12 months since completion of primary cancer treatment and 2 years since diagnosis 3. Serum platelet ≥ 100,000/mm3 4. Serum hemoglobin ≥ 10g/dl 5. Not met one or more behavior goals: i) energy expenditure of aerobic exercise ≥ 12.5 kcal/kg/week; ii) intake of vegetables except kimchi ≥ 5 serv/day and intake of fruit 1-2 serv/day; iii) maintenance of healthy weight (18.5 kg/m2 ≤ BMI \< 23 kg/m2) 6. Ability to use internet, and being accessible internet at home 7. Mobile phone user 8. Consent form to participate in the study Exclusion Criteria: 1. Currently receiving any cancer treatment 2. Conditions that could limit adherence to an unsupervised exercise program such as uncontrolled congestive heart failure or angina, recent myocardial infarction, or breathing difficulties requiring oxygen use or hospitalization; walker or wheelchair use; or plans to have hip or knee replacement 3. Conditions that could interfere with a high vegetable and fruit diet, such as kidney failure or chronic warfarin use 4. Progressive malignant disease or additional primary cancers 5. Infectious condition (body temperature ≥ 37.2℃ or WBC ≥ 11,000mm3) 6. Inability to use computer or internet 7. Visual and motor dysfunction
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 20 Years
Study: NCT01512069
Study Brief:
Protocol Section: NCT01512069